Search PubMedSearch

PubMed · 9636181

Computerized polymorphic marker identification: experimental validation and a predicted human polymorphism catalog.

Abstract

A computational system for the prediction of polymorphic loci directly and efficiently from human genomic sequence was developed and verified. A suite of programs, collectively called POMPOUS (polymorphic marker prediction of ubiquitous simple sequences) detects tandem repeats ranging from dinucleotides up to 250 mers, scores them according to predicted level of polymorphism, and designs appropriate flanking primers for PCR amplification. This approach was validated on an approximately 750-kilobase region of human chromosome 3p21.3, involved in lung and breast carcinoma homozygous deletions. Target DNA from 36 paired B lymphoblastoid and lung cancer lines was amplified and allelotyped for 33 loci predicted by POMPOUS to be variable in repeat size. We found that among those 36 predominately Caucasian individuals 22 of the 33 (67%) predicted loci were polymorphic with an average heterozygosity of 0.42. Allele loss in this region was found in 27/36 (75%) of the tumor lines using these markers. POMPOUS provides the genetic researcher with an additional tool for the rapid and efficient identification of polymorphic markers, and through a World Wide Web site, investigators can use POMPOUS to identify polymorphic markers for their research. A catalog of 13,261 potential polymorphic markers and associated primer sets has been created from the analysis of 141,779,504 base pairs of human genomic sequence in GenBank. This data is available on our Web site (pompous.swmed.edu) and will be updated periodically as GenBank is expanded and algorithm accuracy is improved.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J W Fondon, G M Mele, R I Brezinschek, D Cummings, A Pande, J Wren, K M O'Brien, K C Kupfer, M H Wei, M Lerman, J D Minna, H R Garner. 1998-06-23. Computerized polymorphic marker identification: experimental validation and a predicted human polymorphism catalog.. https://doi.org/10.1073/pnas.95.13.7514

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

An e-mail system for obtaining approval to use a restricted agent.

Because of concerns over cost, proper patient selection, and prescribing patterns, pharmacy and therapeutics committees must be very selective about which new medications can be added to formularies and used in health systems. However, in the final analysis, many problems with important new agents are easily solved when clinicians select the right patients and prescribe these agents properly. Physician specialists in appropriate fields often already know about important new medications from clinical trials, professional meetings, and published articles. In such cases, these specialists can help with the needed diffusion of information to other physicians so that a broad range of prescribers in a health system become familiar with the new agent, its advantages, what types of patients need the drug, and what problems may be encountered.

Computer Communication Networks